82 related articles for article (PubMed ID: 32243310)
21. Association between p16/Ki-67 dual stain cytology results prior to and 6 months after LLETZ treatment for CIN and the follow-up regimen three years after treatment: a retrospective cohort study.
Packet B; Goyens J; Weynand B; Poppe W; Dewilde K
Arch Gynecol Obstet; 2024 May; ():. PubMed ID: 38806944
[TBL] [Abstract][Full Text] [Related]
22. Post-conization surveillance in an organized cervical screening program with more than 23,000 years of follow-up.
Sundqvist A; Nicklasson J; Olausson P; Borgfeldt C
Infect Agent Cancer; 2023 Dec; 18(1):81. PubMed ID: 38057893
[TBL] [Abstract][Full Text] [Related]
23. Cervical cancer in Region Skåne, Sweden 2017-2020 after the implementation of primary HPV screening: A quality assurance audit.
Hellsten C; Holmberg A; Astrom J; Forslund O; Borgfeldt C
Acta Obstet Gynecol Scand; 2024 Jan; 103(1):129-137. PubMed ID: 37817563
[TBL] [Abstract][Full Text] [Related]
24. 2023 Canadian Colposcopy Guideline: A Risk-Based Approach to Management and Surveillance of Cervical Dysplasia.
Willows K; Selk A; Auclair MH; Jim B; Jumah N; Nation J; Proctor L; Iazzi M; Bentley J
Curr Oncol; 2023 Jun; 30(6):5738-5768. PubMed ID: 37366914
[TBL] [Abstract][Full Text] [Related]
25. Risk factors analysis of recurrent disease after treatment with a loop electrosurgical excision procedure for high-grade cervical intraepithelial neoplasia.
Ding T; Li L; Duan R; Chen Y; Yang B; Xi M
Int J Gynaecol Obstet; 2023 Feb; 160(2):538-547. PubMed ID: 35810389
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of E7 mRNA in HPV16-Positive Women to Predict the Risk of Progression to HSIL/CIN2.
Martí C; Marimón L; Glickman A; Henere C; Saco A; Rakislova N; Torné A; Ordi J; Del Pino M
Diagnostics (Basel); 2021 Sep; 11(9):. PubMed ID: 34573975
[TBL] [Abstract][Full Text] [Related]
27. Human Papillomavirus Same Genotype Persistence and Risk of Cervical Intraepithelial Neoplasia2+ Recurrence.
Iacobone AD; Radice D; Sandri MT; Preti EP; Guerrieri ME; Vidal Urbinati AM; Pino I; Franchi D; Passerini R; Bottari F
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359566
[TBL] [Abstract][Full Text] [Related]
28. An Introduction to the 2019 ASCCP Risk-Based Management Consensus Guidelines.
Schiffman M; Wentzensen N; Perkins RB; Guido RS
J Low Genit Tract Dis; 2020 Apr; 24(2):87-89. PubMed ID: 32243305
[No Abstract] [Full Text] [Related]
29. A Systematic Review of Tests for Postcolposcopy and Posttreatment Surveillance.
Clarke MA; Unger ER; Zuna R; Nelson E; Darragh TM; Cremer M; Stockdale CK; Einstein MH; Wentzensen N
J Low Genit Tract Dis; 2020 Apr; 24(2):148-156. PubMed ID: 32243310
[TBL] [Abstract][Full Text] [Related]
30. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
Cox JT;
Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
[TBL] [Abstract][Full Text] [Related]
31. Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Melnikow J; Henderson JT; Burda BU; Senger CA; Durbin S; Weyrich MS
JAMA; 2018 Aug; 320(7):687-705. PubMed ID: 30140883
[TBL] [Abstract][Full Text] [Related]
32. Low Risk of Cervical Cancer/Precancer Among Most Women Under Surveillance Postcolposcopy.
Demarco M; Cheung LC; Kinney WK; Wentzensen N; Lorey TS; Fetterman B; Poitras NE; Befano B; Castle PE; Schiffman M
J Low Genit Tract Dis; 2018 Apr; 22(2):97-103. PubMed ID: 29570564
[TBL] [Abstract][Full Text] [Related]
33. Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.
Demarco M; Lorey TS; Fetterman B; Cheung LC; Guido RS; Wentzensen N; Kinney WK; Poitras NE; Befano B; Castle PE; Schiffman M
J Low Genit Tract Dis; 2017 Oct; 21(4):261-267. PubMed ID: 28953116
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
